Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Tilt Biotherapeutics Ltd is a clinical-stage biotechnology company specializing in the development of novel cancer immunotherapies. Their core focus is on oncolytic viruses, specifically 'armed' viruses designed to work synergistically with T-cell therapies and other immune-oncology treatments. These viruses selectively replicate in and destroy cancer cells while simultaneously stimulating a potent anti-tumor immune response. Tilt aims to address unmet needs in hard-to-treat solid tumors by improving the efficacy of existing and emerging cancer treatments.
The headquarters serves as the central hub for research and development, clinical trial oversight, corporate strategy, and administrative operations.
Located within Biomedicum Helsinki, a leading academic medical research and innovation center, fostering collaboration and access to cutting-edge facilities.
A highly scientific, innovative, and collaborative environment focused on breakthrough research in immuno-oncology. The culture likely emphasizes rigorous scientific inquiry, teamwork, and a patient-centric approach to drug development.
Its location in Helsinki, a significant European hub for life sciences and biotechnology, provides access to skilled talent, research collaborations, and a supportive ecosystem for biotech growth.
Tilt Biotherapeutics Ltd primarily operates from its headquarters in Helsinki, Finland. Its global presence is mainly characterized by its international clinical trial activities, collaborations with research institutions and pharmaceutical partners across Europe and North America, and engagement with regulatory bodies in various key markets as it advances its therapeutic candidates.
Biomedicum Helsinki 1, Haartmaninkatu 8, C-wing, 5th floor
Helsinki
Uusimaa
Finland
No additional office locations available.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, TILT Biotherapeutics Ltd' leadership includes:
TILT Biotherapeutics Ltd has been backed by several prominent investors over the years, including:
Tilt Biotherapeutics has seen some key appointments in its executive team over the past year to strengthen its clinical development and financial leadership. Notably, a new Chief Medical Officer was appointed in mid-2023 and a Chief Financial Officer in early 2024.
Discover the tools TILT Biotherapeutics Ltd uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Tilt Biotherapeutics Ltd likely utilizes common professional email formats for its employees. While not publicly specified, patterns often involve combinations of first name, last name, and initials.
[first_initial][last]@tiltbio.com
Format
jdoe@tiltbio.com
Example
70%
Success rate
Tilt Biotherapeutics Press Releases • February 6, 2024
Tilt Biotherapeutics announced the appointment of Mikko Sorsa, M.Sc. (Econ.), as its new Chief Financial Officer (CFO). Mr. Sorsa brings extensive experience in finance and biotech to support the company's growth and development pipeline....more
Tilt Biotherapeutics Press Releases • October 20, 2023
Tilt Biotherapeutics shared encouraging updated results from its Phase 1 clinical trials involving its oncolytic immunotherapies, TILT-123, in combination with other cancer treatments, at the European Society for Medical Oncology (ESMO) Congress 2023. The data highlighted promising efficacy and safety profiles....more
Tilt Biotherapeutics Press Releases • July 11, 2023
Tilt Biotherapeutics announced the appointment of João Tonini, M.D., as its new Chief Medical Officer. Dr. Tonini will lead the company's clinical development strategy and operations for its portfolio of armed oncolytic viruses....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including TILT Biotherapeutics Ltd, are just a search away.